Pfizer reports loss as COVID-19 revenues shrink
Pfizer reported Tuesday a loss following a sharp fall in the sales of its COVID-19 vaccine and therapeutic from pandemic peaks.
Oct 31, 2023
0
1
Pfizer reported Tuesday a loss following a sharp fall in the sales of its COVID-19 vaccine and therapeutic from pandemic peaks.
Oct 31, 2023
0
1
The annual meeting of the Infectious Diseases Society of America was held this year from Oct. 11 to 15 in Boston and attracted participants from around the world, including scientists, physicians, and other health care professionals.
Oct 31, 2023
0
0
The SARS-CoV-2 virus responsible for COVID-19 can cause severe acute respiratory syndrome, contrasting with other coronaviruses that were known to cause mild seasonal colds prior to its emergence in 2019. This raises the ...
Oct 27, 2023
0
53
Researchers from Karolinska Institutet, among others, have developed a prognostic model that identifies the children most at risk of severe RSV infection. The study, published in The Lancet Digital Health, can show which ...
Oct 26, 2023
0
26
Demand for a new shot that protects babies against respiratory syncytial virus (RSV) has outpaced supply, prompting U.S. health officials to recommend the doses be saved for high-risk infants.
Oct 24, 2023
0
0
Children in child care centers are not spreading COVID-19 at significant rates to caregivers or other children at the center, nor to their households, according to a study led by University of Pittsburgh School of Medicine ...
Oct 24, 2023
0
63
Influenza, COVID-19, the common cold and respiratory syncytial virus (RSV) are among the respiratory viruses that will be circulating this fall and winter seasons. These highly contagious viruses cause similar symptoms, making ...
Oct 20, 2023
0
0
Last year's "triple-demic" marked the beginning of what may be a new normal: a confluence of respiratory infections—RSV, influenza, and COVID-19—will surge as the weather cools each year.
Oct 16, 2023
0
1
Maternal vaccination with a bivalent stabilized prefusion F subunit respiratory syncytial virus (RSV) vaccine (RSVpreF) is projected to reduce the clinical and economic burden of RSV lower respiratory tract illness (LRTI) ...
Oct 16, 2023
0
7
There is wide variability in what the U.S. public knows about the seasonal flu and COVID-19, but some facts are much more strongly associated with an individual's vaccination behavior.
Oct 12, 2023
0
1